"Nitroimidazoles" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
IMIDAZOLES having a nitro moiety.
| Descriptor ID |
D009593
|
| MeSH Number(s) |
D02.640.672 D03.383.129.308.658
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Nitroimidazoles".
Below are MeSH descriptors whose meaning is more specific than "Nitroimidazoles".
This graph shows the total number of publications written about "Nitroimidazoles" by people in this website by year, and whether "Nitroimidazoles" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2014 | 0 | 1 | 1 |
| 2015 | 2 | 0 | 2 |
| 2016 | 2 | 1 | 3 |
| 2017 | 7 | 2 | 9 |
| 2018 | 7 | 8 | 15 |
| 2019 | 5 | 3 | 8 |
To return to the timeline, click here.
Below are the most recent publications written about "Nitroimidazoles" by people in Profiles.
-
Acquired Drug Resistance: Recognizing the Potential of Repurposed Drugs. Clin Infect Dis. 2019 11 13; 69(11):2038-2039.
-
BPaL approved for multidrug-resistant tuberculosis. Lancet Infect Dis. 2019 10; 19(10):1063-1064.
-
Estimating the impact of a novel drug regimen for treatment of tuberculosis: a modeling analysis of projected patient outcomes and epidemiological considerations. BMC Infect Dis. 2019 Sep 09; 19(1):794.
-
Recognition for Chagas disease. Lancet Infect Dis. 2019 07; 19(7):699.
-
Economic value of a therapeutic Chagas vaccine for indeterminate and Chagasic cardiomyopathy patients. Vaccine. 2019 06 19; 37(28):3704-3714.
-
Delamanid, linezolid, levofloxacin, and pyrazinamide for the treatment of patients with fluoroquinolone-sensitive multidrug-resistant tuberculosis (Treatment Shortening of MDR-TB Using Existing and New Drugs, MDR-END): study protocol for a phase II/III, multicenter, randomized, open-label clinical trial. Trials. 2019 Jan 16; 20(1):57.
-
Delamanid: does it have a role in tuberculosis treatment? Lancet Respir Med. 2019 03; 7(3):193-195.
-
Synthesis of [18F]FAZA Using Nosyl and Iodo Precursors for Nucleophilic Radiofluorination. Curr Radiopharm. 2019; 12(1):49-57.
-
Sensitivity to imidazoles/nitroimidazoles in subjects sensitized to methylchloroisothiazolinone/methylisothiazolinone: A simple coincidence? Contact Dermatitis. 2019 Mar; 80(3):181-183.
-
Beneficial effects of benznidazole in Chagas disease: NIH SaMi-Trop cohort study. PLoS Negl Trop Dis. 2018 11; 12(11):e0006814.